Resistance of bacteria in urinary tract infections

被引:52
作者
Chomarat, M [1 ]
机构
[1] Ctr Hosp Lyon Sud, Microbiol Lab, F-69310 Pierre Benite, France
关键词
resistance; bacteria; urinary tract infections;
D O I
10.1016/S0924-8579(00)00281-8
中图分类号
R51 [传染病];
学科分类号
100401 [流行病与卫生统计学];
摘要
Bacterial infection of the urinary tract is a common health problem in young women but also the most common nosocomial infection (> 33%) contributing to the mortality of patients, and increasing the duration and cost of hospitalization. Escherichia coli is the most predominant organism and its prevalence varies in different studies. The high consumption of inappropriately prescribed antibiotics, combined with multiple pathology and frequent use of invasive devices, is a major factor contributing to high levels of resistance. There is a serious decrease in susceptibility of E. coli strains to amoxycillin, due to the presence of R-TEM enzymes, to cotrimoxazole and trimethoprim. Nitrofurantoin and fosfomycin-trometamol remain highly active against urinary Enterobacteriaceae, with over 90% of E. coli being susceptible. Knowledge of the most likely causative organisms and the prevalence of resistance pathogens to antimicrobial agents is essential to select antibiotics and to establish guidelines for the empirical treatment of urinary tract infections. (C) 2000 Elsevier Science B.V. and International Society of Chemotherapy. All rights reserved.
引用
收藏
页码:483 / 487
页数:5
相关论文
共 27 条
[1]
THE EMERGENCE OF HIGHLY FLUOROQUINOLONE-RESISTANT ESCHERICHIA-COLI IN COMMUNITY-ACQUIRED URINARY-TRACT INFECTIONS [J].
AGUIAR, JM ;
CHACON, J ;
CANTON, R ;
BAQUERO, F .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1992, 29 (03) :349-350
[2]
A MULTICENTER STUDY OF THE IN-VITRO ACTIVITY OF CEFOTAXIME, CEFUROXIME, CEFTAZIDIME, OFLOXACIN AND CIPROFLOXACIN AGAINST BLOOD AND URINARY PATHOGENS [J].
AMYES, SGB ;
BAIRD, DR ;
CROOK, DW ;
GILLESPIE, SH ;
HOWARD, AJ ;
OPPENHIEM, BA ;
PEDLER, SJ ;
PAULL, A ;
TOMPKINS, DS ;
LAWRIE, SA .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1994, 34 (05) :639-648
[3]
AVRIL JL, 1993, SEM HOP PARIS, V69, P81
[4]
Antibiotic sensitivity of bacteria associated with community-acquired urinary tract infection in Britain [J].
Barrett, SP ;
Savage, MA ;
Rebec, MP ;
Guyot, A ;
Andrews, N ;
Shrimpton, SB .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1999, 44 (03) :359-365
[5]
DEVELOPMENT OF ANTIBACTERIAL RESISTANCE - THE DUTCH EXPERIENCE [J].
BEUNDERS, AJ .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1994, 33 :17-22
[6]
Pseudomonas aeruginosa in community-acquired urinary tract infection: AFORCOPIBIO 1995-1996 [J].
Cavallo, JD ;
de Mouy, D ;
Fabre, R ;
Garrabe, E ;
Armengaud, M .
MEDECINE ET MALADIES INFECTIEUSES, 1998, 28 (03) :258-259
[7]
Extended spectrum beta-lactamase production and fluorquinolone resistance in pathogens associated with community acquired urinary tract infection [J].
Cormican, M ;
Morris, D ;
Corbett-Feeeney, G ;
Flynn, J .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1998, 32 (04) :317-319
[8]
Sensitivity to fosfomycin for main urinary tract bacteria infections: A survey on female out-patients, 15 to 65 years of age [J].
De Mouy, D ;
Berges, JL ;
Bouilloux, JP ;
Charbit, N ;
Fischer, I ;
Grobost, F ;
Larribet, G ;
Porcher, T .
MEDECINE ET MALADIES INFECTIEUSES, 1997, 27 (11) :903-906
[9]
Enterobacteriaceae from community acquired urinary tract infections: AFORCOPIBIO 1995 [J].
DeMouy, D ;
Cavallo, JD ;
Fabre, R ;
Garrabe, E ;
Grobost, F ;
Armengaud, M ;
Labia, R ;
Antoniotti, G ;
Berges, JL ;
Bouilloux, JP ;
Charbit, N ;
DeClerq, G ;
Fischer, I ;
Larribet, G ;
Payro, G ;
Porcher, T .
MEDECINE ET MALADIES INFECTIEUSES, 1997, 27 :642-645
[10]
CHANGING IN ISOLATION RATES AND RESISTANCE PATTERNS OF ESCHERICHIA-COLI ISOLATED FROM COMMUNITY-ACQUIRED URINARY-TRACT INFECTIONS BETWEEN 1986 AND 1993 [J].
DEMOUY, D ;
LEPARGNEUR, JP ;
AURIOL, JC ;
BANDLER, H ;
LARRIBET, G ;
DECLERCQ, G ;
ARMENGAUD, M .
MEDECINE ET MALADIES INFECTIEUSES, 1994, 24 :539-542